EUVIMEDEUVIMED entdecken
Crossref

The utility of inflammatory biomarkers in predicting overall survival and recurrence in skull base chordoma

Meagan Hoppe, Zachary C Gersey, Nallammai Muthiah, Hussein M Abdallah, Tritan Plute, Hussam Abou-Al-Shaar, Eric W Wang, Carl H Snyderman, Georgios A Zenonos, Paul A Gardner

Neurosurgical Focus · 2024

DOI: 10.3171/2024.2.focus2421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurosurgical Focus, 2024. Verfasst von Meagan Hoppe und 9 weiteren Autor:innen. Beteiligte Einrichtung: 1University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Hauptthemen laut MEDLINE: Chordoma, Skull Base Neoplasms, Neoplasm Recurrence, Local, Inflammation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Numerous studies have investigated the impact of inflammatory factors in cancer, yet few attempts have been made to investigate these markers in skull base chordoma (SBC). Inflammatory values including neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), lymphocyte-monocyte ratio (LMR), systemic immune inflammation index (SII), and systemic inflammation response index (SIRI) can serve as prognostic markers in various cancers. This study aimed to determine whether these inflammatory factors influence overall survival (OS) or progression-free survival (PFS) in patients with primary SBC. METHODS The electronic medical records of patients with primary SBC who underwent resection from 2001 to 2020 were retrospectively reviewed for the associations of sex, age at diagnosis, preoperative steroid use, tumor volume, extent of resection, adjuvant radiation after surgery, tumor metastasis, Ki-67 index, percent homozygous deletion of 9p23 and percent 1p36 loss, and potential prognostic inflammatory markers of NLR, PLR, LMR, SII, and SIRI with the primary outcome measures of OS and PFS. Maximum log-rank statistical tests were used to determine inflammatory marker thresholds for grouping prior to Kaplan-Meier and Cox proportional hazards analysis for OS and PFS of the elucidated groups. RESULTS The cohort included 115 primary SBC patients. The mean ± SD tumor volume was 23.0 ± 28.0 cm 3 , 73% of patients received gross-total resection, 40% received postoperative radiation, 25% had local recurrence, and 6% had subsequent metastatic disease (mean follow-up 47.2 months). Univariable Cox analysis revealed that NLR (p < 0.01), PLR (p = 0.04), LMR (p = 0.04), SII (p < 0.01), and SIRI (p < 0.01) were independently associated with PFS. Additionally, NLR (p = 0.05) and SII (p = 0.03) were significant in multivariable Cox analysis of PFS. However, both univariable and multivariable Cox analysis revealed no correlations with OS. CONCLUSIONS The routine assessment of inflammatory biomarkers such as NLR and SIRI could have prognostic value in postresection SBC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChordomaSkull Base NeoplasmsNeoplasm Recurrence, LocalInflammationHumansMaleFemaleMiddle AgedAdultRetrospective StudiesAgedBiomarkers, TumorPrognosisLymphocytesNeutrophilsYoung Adult

Stichwörter der Autor:innen

biomarkerschordomainflammationskull basesurvival analysis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • 1University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Departments of2Neurological Surgery and.
  • 3Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Zitieren

APA

Hoppe, M., Gersey, Z. C., Muthiah, N., Abdallah, H. M., Plute, T., Abou-Al-Shaar, H., Wang, E. W., Snyderman, C. H., Zenonos, G. A., & Gardner, P. A. (2024). The utility of inflammatory biomarkers in predicting overall survival and recurrence in skull base chordoma. Neurosurgical Focus. https://doi.org/10.3171/2024.2.focus2421

Vancouver

Hoppe M, Gersey ZC, Muthiah N, Abdallah HM, Plute T, Abou-Al-Shaar H, et al. The utility of inflammatory biomarkers in predicting overall survival and recurrence in skull base chordoma. Neurosurgical Focus. 2024. doi:10.3171/2024.2.focus2421

BibTeX
@article{Hoppe2024,
  author = {Hoppe, Meagan and Gersey, Zachary C and Muthiah, Nallammai and Abdallah, Hussein M and Plute, Tritan and Abou-Al-Shaar, Hussam and Wang, Eric W and Snyderman, Carl H and Zenonos, Georgios A and Gardner, Paul A},
  title = {The utility of inflammatory biomarkers in predicting overall survival and recurrence in skull base chordoma},
  journal = {Neurosurgical Focus},
  year = {2024},
  doi = {10.3171/2024.2.focus2421}
}
Kostenlos starten →